Economic Implications of Amenable Mortality in India.

Srikanth Reddy Umenthala, International Institute For Population Sciences

This study quantifies the economic cost of amenable deaths in India, emphasizing the relationship between poor healthcare quality, mortality, and economic loss. Despite advancements in healthcare access, systemic deficiencies continue to lead to preventable deaths and economic burdens. By employing the amenable mortality indicator, the research highlights the necessity for improved healthcare quality to enhance public health and guide policy, particularly in resource-limited settings.Data from the Global Burden of Disease (GBD) for 2000, 2010, and 2019 were analyzed across various diseases, age groups, and sexes. We estimated the Value of Statistical Life Years (VSLY) lost due to amenable mortality, reflecting societal welfare losses from preventable deaths. In 2019, of 9.4 million total deaths in India, 3.3 million were amenable to effective healthcare, marking a 10% decline from 2000. The VSLY lost due to amenable deaths rose from $1.76 trillion in 2000 to $4.07 trillion in 2019, indicating an increased economic burden. The shift from communicable to non-communicable diseases (NCDs) is notable, with high amenable mortality among infants and persistent disparities in healthcare access. This underscores the urgent need for targeted prevention programs and enhanced healthcare quality.

Keywords: Health and Morbidity, Economic Demography, Mortality and Longevity

See paper.